AAIS
EW icon

ABN AMRO Investment Solutions’s Edwards Lifesciences EW Stock Holding History

ABN AMRO Investment Solutions’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.5M Buy
425,838
+272,807
+178% +$22.9M 0.33% 63
2026
Q1 		$12.3M Buy
153,031
+128,612
+527% +$10.6M 0.16% 115
2025
Q4 		$2.08M Buy
24,419
+19,123
+361% +$1.57M 0.03% 317
2025
Q3 		$412K Hold
5,296
– – 0.01% 357
2025
Q2 		$414K Buy
5,296
+34
+0.6% +$2.54K 0.01% 360
2025
Q1 		$381K Sell
5,262
-35,773
-87% -$2.56M 0.01% 353
2024
Q4 		$3.04M Buy
41,035
+2,135
+5% +$149K 0.06% 211
2024
Q3 		$2.57M Buy
38,900
+32,430
+501% +$2.36M 0.04% 234
2024
Q2 		$598K Buy
6,470
+3,697
+133% +$327K 0.01% 378
2024
Q1 		$265K Hold
2,773
– – ﹤0.01% 397
2023
Q4 		$211K Buy
+2,773
New +$193K ﹤0.01% 413
2023
Q3 		– Sell
-2,179
Closed -$206K – 416
2023
Q2 		$206K Buy
+2,179
New +$189K ﹤0.01% 401

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ABN AMRO Investment Solutions's EW Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its Edwards Lifesciences (EW) stake by 178% in Q2 2026, buying an estimated $22.9M and bringing the position to 425,838 shares worth $38.5M. The position accounts for 0.33% of the portfolio, ranked #63.

ABN AMRO Investment Solutions first reported a position in EW in Q2 2023 and has held it in 12 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • ABN AMRO Investment Solutions held 425,838 shares of Edwards Lifesciences worth $38.5M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 272,807 Edwards Lifesciences shares in Q2 2026, an estimated $22.9M.
  • Edwards Lifesciences made up 0.33% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #63 holding.
  • ABN AMRO Investment Solutions first reported a position in Edwards Lifesciences in Q2 2023 and has held it in 12 quarters since.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.